Director/PDMR Shareholding

IP Group PLC

29 June 2023

 

FOR RELEASE ON

29 June 2023

IP Group plc -Additional DBSP awards; PDMR shareholding

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces the following in connection with its employee share schemes.

Deferred Bonus Share Plan ("DBSP") Awards

On 14 April 2023, the Company granted a number of nil-cost options over ordinary shares of two pence each ("Shares") to certain employees under the Group's DBSP, such awards being announced to the market via RNS on 18 April 2023 (the "April 2023 DBSP Awards").

It was subsequently noted that there had been an administrative error in calculating a small number of the April 2023 DBSP Awards. As such, on 28 June 2023 the Company granted additional nil-cost options over Shares to a person discharging managerial responsibilities ("PDMR") and certain current and former employees under the Group's DBSP (the "Additional Grant"). The Additional Grant has been made on the same basis as the April 2023 DBSP Awards were made. The following table sets out details of the awards made to a PDMR: 

Name of Director/PDMR	Structure of award	Number of options granted under the April 2023 DBSP	Number of options granted under the Additional Grant	Total number of options currently held
Mark Reilly	Nil-Cost Option	75,376	4,636	127,380
Total

In addition to the above, under the Additional Grant, awards over a total of 24,202 Shares were made to certain other of the Group's employees and former employees. As at the date of this announcement, a total of 2,168,457 nil-cost options over Shares remain outstanding under the IP Group DBSP. 

No consideration was paid for the grant of the awards and no consideration is due on the maturity of the option period. Fifty per cent of the options will normally be automatically exercised on 31 March 2024 and fifty per cent on 31 March 2025, with each such automatic exercise generally subject to continued employment.

Shares in issue

At the date of this announcement, the Company continues to have 1,063,188,005 Shares in issue of which 26,273,218 Shares are held in treasury.

The following information is being disclosed pursuant to the requirements of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

DBSP Awards

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Mark Reilly
2	Reason for the notification
a)	Position/status	PDMR          Managing Partner, Technology
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	IP Group plc
b)	Legal Entity Identifier	213800HG22UM138WFG43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 2p each in IP Group plc   ISIN: GB00B128J450
b)	Nature of the transaction	Grant of nil-cost options under the IP Group plc DBSP
c)	Currency	GBP
d)	Price(s) and volume(s)	Name(s) Price(s) Volume(s) Mark Reilly Nil cost option 4,636
e)	Aggregated information -Aggregated volume - Price - Aggregated total	Aggregated number of options granted under the DBSP to Directors and PDMRs on 28 June 2023: 4,636 Price: £ nil
f)	Date of the transaction	28 June 2023
g)	Place of the transaction	Outside a trading venue

For more information, please contact:

IP Group plc	www.ipgroupplc.com
Liz Vaughan-Adams, Communications    Portland Vic Wallin Alex Donaldson	[phone]/[phone] [phone] [phone]

Notes for editors

About IP Group

IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com.

ENDS

 

END